Product Comparison

Comparison Options

• Print
• Email

	No Image
McKesson #	1105285	981867	952614	304337
Description	Beaded Chain	TDVAX™ Tetanus and Diphtheria Toxoids Adsorbed 2 Lf - 2 Lf / 0.5 mL Injection 0.5 mL	Gardasil® 9 Human Papillomavirus 9-Valent Vaccine, Recombinant, Preservative Free 20 mcg - 60 mcg / 0.5 mL Injection 0.5 mL	M-M-R® II Measles, Mumps, and Rubella Vaccine, Preservative Free 1,000 TCID - 12,500 TCID - 1,000 TCID / 0.5 mL Injection 0.5 mL
Manufacturer #	PAR9818	13533013101	00006412102	00006468100
Brand		TDVAX™	Gardasil® 9	M-M-R® II
Manufacturer	Invacare	Grifols Therapeutics Inc (TDVAX)	Merck	Merck
Invoice		TDVAX, SDV 0.5ML (10/PK)	GARDASIL 9 HPV VACC, SYR 0.5ML(10/BX)	M-M-R II, SDV (10/BX)
	Log In to Order	Log In to Order	Log In to Order	Log In to Order
Comparison
Application		Td Vaccine	Human Papillomavirus Vaccine (HPV)	MMR Vaccine
Container Type		Single-Dose Vial	Prefilled Syringe	Single-Dose Vial
Country of Origin	Unknown	Unknown	United States	United States
Dosage Form		Injection	Injection	Injection
Generic Drug Code		20835	37568	99568
Generic Drug Name		Tetanus and Diphtheria Toxoids Adsorbed	Human Papillomavirus 9-Valent Vaccine, Recombinant, Preservative Free	Measles, Mumps, and Rubella Vaccine, Preservative Free
NDC Number		13533013101	00006412102	00006468100
Product Dating		McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 180 days	McKesson Acceptable Dating: we will ship >= 90 days
Storage Requirements		Requires Refrigeration	Requires Refrigeration	Requires Refrigeration
Strength		2 Lf - 2 Lf / 0.5 mL	20 mcg - 60 mcg / 0.5 mL	1,000 TCID - 12,500 TCID - 1,000 TCID / 0.5 mL
Type		Intramuscular	Intramuscular	Intravenous or Subcutaneous
UNSPSC Code		51201629	51201649	51201628
User		Indicated for People 7 Years of Age and Older	Indicated for People 9 to 45 Years of Age	Indicated for People 12 Months of Age and Older
Volume		0.5 mL	0.5 mL	0.5 mL
Features and Benefits			GARDASIL 9 is a non-infectious recombinant 9-valent vaccine prepared from the purified virus-like particles (VLPs) of the major capsid (L1) protein of HPV Types 6, 11, 16, 18, 31, 33, 45, 52, and 58 Each 0.5-mL dose contains approximately 30 mcg of HPV Type 6 L1 protein, 40 mcg of HPV Type 11 L1 protein, 60 mcg of HPV Type 16 L1 protein, 40 mcg of HPV Type 18 L1 protein, 20 mcg of HPV Type 31 L1 protein, 20 mcg of HPV Type 33 L1 protein, 20 mcg of HPV Type 45 L1 protein, 20 mcg of HPV Type 52 L1 protein, and 20 mcg of HPV Type 58 L1 protein Administer GARDASIL 9 intramuscularly as a 0.5-mL dose at the following schedule: 0, 2 months, 6 months Not all vulvar, vaginal, and anal cancers are caused by HPV, and GARDASIL 9 protects only against those vulvar, vaginal, and anal cancers caused by HPV 16, 18, 31, 33, 45, 52 and 58	Preservative free M-M-R II* is supplied as: (1) a box of 10 single-dose vials of lyophilized vaccine and (2) a box of 10 vials of diluent Store vials at 2 - 8 degrees Celsius (36 - 46 degrees Fahrenheit) The diluent may be stored in the refrigerator with the lyophilized vaccine or separately at room temperature